Profil bibliographique

Nikolaos Tsamandouras

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

25Publications signalées

1677Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsDiabetes Treatment and ManagementBariatric Surgery and OutcomesAnalytical Chemistry and Chromatography

Publications récentes

Accès ouvert 2026 articleOpenAlex

Assessment of the Drug–Drug Interaction Potential of Lotiglipron (PF‐07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol

Carol Cronenberger, Neeta B. Amin, Vu Le, Santos Carvajal‐Gonzalez et autres

0 citationsThe Journal of Clinical Pharmacology

Accès ouvert 2025 articleOpenAlex

Efficacy and safety of danuglipron ( PF ‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study

Clare Buckeridge, Sonia Cobain, Harold Bays, Osamu Matsuoka et autres

22 citationsDiabetes Obesity and Metabolism

2025 peer-reviewOpenAlex

Author response for "Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b study"

Clare Buckeridge, Sonia Cobain, Harold E. Bays, Osamu Matsuoka et autres

0 citations

Accès ouvert 2024 articleOpenAlex

Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study

Neeta B. Amin, Robert Frederich, Nikolaos Tsamandouras, Amina Z. Haggag et autres

28 citationsDiabetes Obesity and Metabolism

Accès ouvert 2024 articleOpenAlex

Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis

Spencer I. Danto, Nikolaos Tsamandouras, Padma Reddy, Steven A. Gilbert et autres

2 citationsAllergy Asthma and Clinical Immunology

Accès ouvert 2024 articleOpenAlex

Once‐daily oral small‐molecule glucagon‐like peptide‐1 receptor agonist lotiglipron (PF‐07081532) for type 2 diabetes and obesity: Two randomized, placebo‐controlled, multiple‐ascending‐dose Phase 1 studies

Clare Buckeridge, Nikolaos Tsamandouras, Santos Carvajal‐Gonzalez, Lisa Brown et autres

17 citationsDiabetes Obesity and Metabolism

Accès ouvert 2024 articleOpenAlex

Employing zero-inflated beta distribution in an exposure-response analysis of TYK2/JAK1 inhibitor brepocitinib in patients with plaque psoriasis

Nikolaos Tsamandouras, Ruolun Qiu, Jim H. Hughes, Kevin Sweeney et autres

6 citationsJournal of Pharmacokinetics and Pharmacodynamics

Accès ouvert 2023 articleOpenAlex

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF‐06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study

Spencer I. Danto, Nikolaos Tsamandouras, Padmalatha S. Reddy, Steven A. Gilbert et autres

6 citationsThe Journal of Clinical Pharmacology

Accès ouvert 2023 articleOpenAlex

Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes

Aditi R. Saxena, Juan P. Frías, Donal Gorman, Rene N. Lopez et autres

42 citationsDiabetes Obesity and Metabolism

Accès ouvert 2023 articleOpenAlex

Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes

Aditi R. Saxena, Juan P. Frías, Lisa Brown, Donal Gorman et autres

140 citationsJAMA Network Open

2019 articleOpenAlex

Impact of Phase 1 study design on estimation of QT interval prolongation risk using exposure–response analysis

Nikolaos Tsamandouras, Sridhar Duvvuri, Steve Riley

4 citationsJournal of Pharmacokinetics and Pharmacodynamics

Accès ouvert 2018 articleOpenAlex

Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics

Aarti Sawant‐Basak, A. David Rodrigues, Matthew P. Lech, Régis Doyonnas et autres

16 citationsDrug Metabolism and Disposition

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.